Dual HER2 Targeted Therapy With Pyrotinib and Trastuzumab in Refractory HER2 Positive Metastatic Colorectal Cancer: A Result From HER2-FUSCC-G Study
Jinjia Chang, Midie Xu, Chenchen Wang, Dan Huang, Zhe Zhang, Zhiyu Chen, Xiaodong Zhu, Wenhua Li
Topics & Concepts
MedicineTrastuzumabInternal medicineOncologyColorectal cancerRefractory (planetary science)Clinical endpointPopulationAdverse effectCancerGastroenterologyClinical trialBreast cancerAstrobiologyPhysicsEnvironmental healthHER2/EGFR in Cancer ResearchColorectal Cancer Treatments and StudiesAdvanced Breast Cancer Therapies